Paid PCOS (Polycystic Ovary Syndrome) Clinical Trials
PCOS clinical trials recruiting. Access new treatments for hormonal symptoms. Compensation up to $2,400. Studies for women with polycystic ovary syndrome.
Compensation
$1,200 - $2,400
Duration
16-52 weeks
Phase
Phase II/III
FDA Regulated
IRB Approved
GCP Certified
Who May Qualify
- Age 18-45 years
- Diagnosis of PCOS (Rotterdam criteria)
- Irregular menstrual cycles or anovulation
- Clinical or biochemical hyperandrogenism
- BMI typically 18-40 kg/m²
- Willingness to use non-hormonal contraception
Who May Not Qualify
- Current pregnancy or breastfeeding
- Congenital adrenal hyperplasia
- Androgen-secreting tumors
- Uncontrolled thyroid disease
- Current use of hormonal contraceptives (washout required)
Frequently Asked Questions
What PCOS treatments are being studied?
+
Studies include new medications targeting androgen excess, insulin sensitizers, treatments to restore ovulation, and approaches to manage metabolic aspects of PCOS.
Will studies help with fertility?
+
Some studies specifically target ovulation induction for women trying to conceive, while others focus on symptom management. Studies clearly indicate whether they are appropriate for women seeking pregnancy.
How are hormones monitored?
+
Blood tests measure androgens (testosterone, DHEAS), insulin, and other hormones at multiple timepoints. Ovulation may be monitored through blood tests or ultrasound.
What about studies for related symptoms like hirsutism?
+
Yes, some studies specifically target symptoms like hirsutism (excess hair growth) or acne. These may use different outcome measures focused on visible symptoms.